Valerio Therapeutics Société anonyme (EPA:ALVIO)
France · Delayed Price · Currency is EUR 0.5090
-0.0200 (-3.78%)
Oct 2, 2026, 5:35 PM CET
EPA:ALVIO Market Cap
EPA:ALVIO has a market cap or net worth of €264.21 million as of October 2, 2026. Its market cap has increased by 2,392.37% in one year.
Market Cap
264.21M
Enterprise Value
271.47M
Revenue
2.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.51
ChartMarket Cap Chart
Since December 8, 2005, EPA:ALVIO's market cap has increased from 72.77M to 264.21M, an increase of 263.08%. That is a compound annual growth rate of 6.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 264.21M | 291.65% |
| Dec 31, 2025 | 67.46M | 484.18% |
| Dec 31, 2024 | 11.55M | -54.58% |
| Dec 29, 2023 | 25.42M | 62.58% |
| Dec 30, 2022 | 15.64M | -59.41% |
| Dec 31, 2021 | 38.52M | -25.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MedinCell | 865.47M |
| Inventiva | 678.12M |
| DBV Technologies | 613.73M |
| Valneva SE | 513.94M |
| Genfit | 496.24M |
| Transgene | 197.74M |
| Innate Pharma | 128.18M |
| Cellectis | 97.05M |